Therefore, both animal and clinical studies (Table 1) revealed an important role for NLRP3 inflammasome in the pathogenesis of AD and strategies targeting the NLRP3–caspase-1 pathway are being investigated to find a cure for AD.88–96. Here, CASP1 is linked to Alzheimer disease.